Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis c virus

Hepatology

Volumn 25, Issue 5, 1997, Pages 1245-1249

  Zibert, Andree ^a   Meisel, Helga ^b   Kraas, Wolfgang ^c   Schulz, Angelika ^b   Jung, Günther ^c   Roggendorf, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Institut fur Organische Chemie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0030904821     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250530     Document Type: Article

References (17)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989;244:359-362.
2. Alter HJ. In: Seeff LB, Lewis JH, eds. Current Perspectives in Hepatology. New York: Plenum, 1989:83-97.
3. Chien, DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo, G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993;342:435-436.
4. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
5. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
6. Choo Q-L, Kuo G, Ralston R, Weiner AJ, Chien D, van Nest G, Han J, et al. Vaccination of chimpanzees against infection by hepatitis C virus. PNAS 1994;91:1294-1298.
7. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
8. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994;343:388-390.
9. Courouce AM, Bouchardeau F, Chauveau P, Le MN, Girault A, Zins B, Naret C, et al. Hepatitis C virus (HCV) infection in haemodialysed patients. HCV RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995;10:234-239.
10. Duvoux C, Pawlotsky JM, Cherqui D, Tran vNJ, Metreau JM, Fagniez PL, Duval J, et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995;60:457-461.
11. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.
12. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. PNAS 1992;89:3468-3472.
13. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994;68:4776-4784.
14. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993;195:297-301.
15. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. PNAS 1996;93:1759-1763.
16. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS 1994;91:7792-7796.
17. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-661.